The changing epidemiology of Ebstein's anomaly and its relationship with maternal mental health conditions: A European registry-based study

Cardiology in the Young

Volumn 27, Issue 4, 2017, Pages 677-685

  Boyle, Breidge ^a   Garne, Ester ^b   Loane, Maria ^a   Addor, Marie Claude ^c   Arriola, Larraitz ^d   Cavero Carbonell, Clara ^e   Gatt, Miriam ^f   Lelong, Nathalie ^g   Lynch, Catherine ^h   Nelen, Vera ⁱ   Neville, Amanda J ^j   O'Mahony, Mary ^h   Pierini, Anna ^k   Rissmann, Anke ^l   Tucker, David ^m   Zymak Zakutnia, Natalia ⁿ   Dolk, Helen ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b KOLDING HOSPITAL   (Denmark)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^e Foundation for the Promotion of Health and Biomedical Research in the Valencian Region   (Spain)

^f Department of Health Information and Research Guardamangia ^*  (Malta)

^g INSERM   (France)

^h HEALTH SERVICE EXECUTIVE   (Ireland)

ⁱ PIH   (Belgium)

^j UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^k INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^l OTTO VON GUERICKE UNIVERSITY   (Germany)

^m PUBLIC HEALTH WALES   (United Kingdom)

ⁿ Khmelnytsky Regional Medical Genetic Centre   (Ukraine)

more..

Author keywords

antidepressants; Ebstein's anomaly; mental illness; prevalence; psycholeptics

Indexed keywords

ADULT; ARTICLE; BETA THALASSEMIA; BLEEDING; CONTROLLED STUDY; EBSTEIN ANOMALY; FEMALE; FETUS DEATH; FIRST TRIMESTER PREGNANCY; HUMAN; LIVE BIRTH; MAJOR CLINICAL STUDY; MATERNAL WELFARE; MENTAL DISEASE; POPULATION RESEARCH; PREGNANCY TERMINATION; PREVALENCE; ADOLESCENT; EUROPE; MALE; MATERNAL EXPOSURE; NEWBORN; PREGNANCY; PREGNANCY OUTCOME; REGISTER; YOUNG ADULT;

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; LITHIUM;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; BENZODIAZEPINES; BETA-THALASSEMIA; EBSTEIN ANOMALY; EUROPE; FEMALE; FETAL DEATH; HUMANS; INFANT, NEWBORN; LITHIUM; MALE; MATERNAL EXPOSURE; MENTAL DISORDERS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY TRIMESTER, FIRST; REGISTRIES; YOUNG ADULT;

EID: 84984693671     PISSN: 10479511     EISSN: 14671107     Source Type: Journal    
DOI: 10.1017/S1047951116001025     Document Type: Article

References (35)

1. van Son JA, Konstantinov IE, et al. Wilhelm Ebstein and Ebstein's malformation. Eur J Cardiothorac Surg 2001; 20: 1082-1085.
2. Oxenius A, Attenhofer Jost CH, Pretre R, et al. Management and outcome of Ebstein's anomaly in children. Cardiol Young 2013; 23: 27-34.
3. Zimmer EZ, Blazer S, Lorber A, et al. Fetal Ebstein's anomaly: early and late appearance. Prenat Diagn 2012; 32: 228-233.
4. Celermajer DS, Bull C, Till JA, et al. Ebstein's anomaly: presentation and outcome from fetus to adult. J Am Coll Cardiol 1994; 23: 170-176.
5. Nora JJ, Nora AH, Toews WH. Letter: lithium, Ebstein's anomaly, and other congenital heart defects. Lancet 1974; 2: 594-595.
6. NICE. Antenatal and postnatal mental health: clinical management and service guidance-updated version. 2014; Retrieved February 11, 2015 from http://www.nice.org.uk/guidance/cg192/evidence/cg192-antenatal-and-postnatal-mental-health-full-guideline3.
7. Diav-Citrin O, Shechtman S, Tahover E, et al. Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry 2014; 171: 785-794.
8. Correa-Villasenor A, Ferencz C, Neill CA, et al. Ebstein's malformation of the tricuspid valve: genetic and environmental factors. The Baltimore-Washington infant study group. Teratology 1994; 50: 137-147.
9. Caton AR, Bell EM, Druschel CM, et al. Antihypertensive medication use during pregnancy and the risk of cardiovascular malformations. Hypertension 2009; 54: 63-70.
10. Ozkan H, Cetinkaya M, Koksal N, et al. Severe fetal valproate syndrome: combination of complex cardiac defect, multicystic dysplastic kidney, and trigonocephaly. J Matern Fetal Neonatal Med 2011; 24: 521-524.
11. Jenkins KJ, Correa A, Feinstein JA, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association Council on cardiovascular disease in the young: endorsed by the American Academy of Pediatrics. Circulation 2007; 115: 2995-3014.
12. Wemakor A, Casson K, Garne E, et al. Selective serotonin reuptake inhibitor antidepressant use in first trimester pregnancy and risk of specific congenital anomalies: a European register-based study. Eur J Epidemiol 2015; 11: 1187-1198.
13. Boyd PA, Haeusler M, Barisic I, et al. Paper 1: the EUROCAT network-organization and processes. Birth Defects Research 2011; 91 (Suppl 1): S2-15.
14. Greenlees R, Neville A, Addor MC, et al. Paper 6: EUROCAT member registries: organization and activities. Birth Defects Res A Clin Mol Teratol 2011; 91 (Suppl 1): S51-S100.
15. EUROCAT. EUROCAT: Guide 1.3 and Reference Documents. 2013. Retrieved April 7, 2014 from http://www.eurocat-network. eu/content/EUROCAT-Guide-1.3.pdf.
16. Cowie CC, Rust KF, Ford ES, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care 2009; 32: 287-294.
17. Correa A, Gilboa SM, Besser LM, et al. Diabetes mellitus and birth defects. Am J Obstet Gynecol 2008; 199: 237. e1-237.e9.
18. Monk C, Newport DJ, Korotkin JH, et al. Uterine blood flow in a psychiatric population: impact of maternal depression, anxiety, and psychotropic medication. Biol Psychiatry 2012; 72: 483-490.
19. Hasan SS, Clavarino AM, Dingle K, et al. Psychological health and the risk of diabetes mellitus in Australian women: a 21-year prospective study. J Womens Health (Larchmt) 2014; 23: 912-919.
20. Garne E, Loane M, Dolk H, et al. Spectrum of congenital anomalies in pregnancies with pregestational diabetes. Birth Defects Res A Clin Mol Teratol 2012; 94: 134-140.
21. Botto LD, Panichello JD, Browne ML, et al. Congenital heart defects after maternal fever. Am J Obstet Gynecol 2014; 210: 359. e1-359.e11.
22. Forrester MB, Merz RD. Descriptive epidemiology of selected congenital heart defects, Hawaii, 1986-1999. Paediatr Perinat Epidemiol 2004; 18: 415-424.
23. Reller MD, Strickland MJ, Riehle-Colarusso T, et al. Prevalence of congenital heart defects in metropolitan Atlanta, 1998-2005. J Pediatr 2008; 153: 807-813.
24. Lupo PJ, Langlois PH, Mitchell LE. Epidemiology of Ebstein anomaly: prevalence and patterns in Texas, 1999-2005. Am J Med Genet A. 2011; 155A: 1007-1014.
25. Dolk H, Loane M, Garne E, European Surveillance of Congenital Anomalies (EUROCAT) Working Group. congenital heart defects in Europe: prevalence and perinatal mortality, 2000 to 2005. Circulation 2011; 123: 841-849.
26. Khoshnood B, Loane M, Garne E, et al. Recent decrease in the prevalence of congenital heart defects in Europe. J Pediatr 2013; 162: 108-13.e2.
27. Special Report: Prenatal Screening Policies in Europe 2010, Retrieved February 2, 2016 from http://www.eurocat-network.eu/aboutus/publications/publications.
28. Postma AV, van Engelen K, van de Meerakker J, et al. Mutations in the sarcomere gene MYH7 in Ebstein anomaly. Circ Cardiovasc Genet 2011; 4: 43-50.
29. McIntosh N, Chitayat D, Bardanis M, et al. Ebstein anomaly: report of a familial occurrence and prenatal diagnosis. Am J Med Genet 1992; 42: 307-309.
30. Attenhofer Jost CH, Connolly HM, Dearani JA, et al. Ebstein's anomaly. Circulation 2007; 115: 277-285.
31. Manning N. The influence of twinning on cardiac development. Early Hum Dev 2008; 84: 173-179.
32. Verp MS. Pregnancy loss: multiple pregnancy versus multiple birth. In: Blickstein I, Keith L, eds Multiple Pregnancy Epidemiology, Gestation and Perinatal Outcome, 2nd edn. Taylor and Francis, New York, 2005: 252-255.
33. Schlesselman J. Case-Control Studies. Oxford University Press, Oxford, 1982.
34. Dolk H, Wemakor A. Case-control studies require appropriate population controls: an example of error in the SSRI birth defect literature. Eur J Epidemiol 2015; 30: 1219-1221.
35. Prieto L, Martinez-Frias ML. Case-control studies using only malformed infants: are we interpreting the results correctly? Teratology 1999; 60: 1-2.